Takeda Pharmaceutical Co Ltd
(LTS:0A87)
$
14.07
-0.11 (-0.78%)
Market Cap: 44.60 Bil
Enterprise Value: 75.52 Bil
PE Ratio: 44.54
PB Ratio: 0.84
GF Score: 77/100 Full Year 2022 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript
May 11, 2022 / 10:00AM GMT
Release Date Price:
$14.01
(-3.48%)
Ayako Iwamuro
Takeda Pharmaceutical Company Limited - Manager of IR and Global Finance
Presentation
May 11, 2022 / 10:00AM GMT
=====================
Corporate Participants
=====================
* Andrew S. Plump
Takeda Pharmaceutical Company Limited - President of Research & Development and Representative Director
* Ayako Iwamuro
Takeda Pharmaceutical Company Limited - Manager of IR and Global Finance
* Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director
* Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Representative Director
=====================
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot